Literature DB >> 19779698

Selection of a Clostridium perfringens type D epsilon toxin producer via dot-blot test.

Luciana A Gonçalves1, Zélia I P Lobato, Rodrigo O S Silva, Felipe M Salvarani, Prhiscylla S Pires, Ronnie A Assis, Francisco C F Lobato.   

Abstract

Clostridium perfringens type D produces enterotoxemia, an enteric disease in ruminants, also known as pulpy kidney disease. Caused by epsilon toxin, enterotoxemia is a major exotoxin produced by this microorganism. Epsilon toxin is also the main component of vaccines against this enteric disorder. In this study, a standardized dot-blot was used to choose strains of C. perfringens type D that are producers of epsilon toxin. Clones producing epsilon toxin were chosen by limiting dilution; after three passages, lethal minimum dose titers were determined by soroneutralization test in mice. These clones produced epsilon toxin 240 times more concentrated than the original strain. The presence of the epsilon toxin gene (etx) was verified by polymerase chain reaction. All clones were positive, including those determined to be negative by dot-blot tests, suggesting that mechanisms in addition to the presence of the etx gene can influence toxin production. The dot-blot test was efficient for the selection of toxigenic colonies of C. perfringens type D and demonstrated that homogeneous populations selected from toxigenic cultures produce higher titers of epsilon toxin.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19779698     DOI: 10.1007/s00203-009-0510-y

Source DB:  PubMed          Journal:  Arch Microbiol        ISSN: 0302-8933            Impact factor:   2.552


  4 in total

1.  The Myelin and Lymphocyte Protein MAL Is Required for Binding and Activity of Clostridium perfringens ε-Toxin.

Authors:  Kareem Rashid Rumah; Yinghua Ma; Jennifer R Linden; Myat Lin Oo; Josef Anrather; Nicole Schaeren-Wiemers; Miguel A Alonso; Vincent A Fischetti; Mark S McClain; Timothy Vartanian
Journal:  PLoS Pathog       Date:  2015-05-20       Impact factor: 6.823

2.  Immunogenicity of a Trivalent Recombinant Vaccine Against Clostridium perfringens Alpha, Beta, and Epsilon Toxins in Farm Ruminants.

Authors:  Gustavo Marçal Schmidt Garcia Moreira; Felipe Masiero Salvarani; Carlos Eduardo Pouey da Cunha; Marcelo Mendonça; Ângela Nunes Moreira; Luciana Aramuni Gonçalves; Prhiscylla Sadanã Pires; Francisco Carlos Faria Lobato; Fabricio Rochedo Conceição
Journal:  Sci Rep       Date:  2016-03-23       Impact factor: 4.379

3.  Development of a double-recombinant antibody sandwich ELISA for quantitative detection of epsilon toxoid concentration in inactivated Clostridium perfringens vaccines.

Authors:  Maryam Alibeiki; Mehdi Golchin; Mohammad Tabatabaei
Journal:  BMC Vet Res       Date:  2020-09-29       Impact factor: 2.741

4.  Measurement over 1 Year of Neutralizing Antibodies in Cattle Immunized with Trivalent Vaccines Recombinant Alpha, Beta and Epsilon of Clostridium perfringens.

Authors:  Cleideanny C Galvão; José D Barbosa; Carlos M C Oliveira; Denis Y Otaka; Paulo R O Silva; Marcos R A Ferreira; Clóvis Moreira Júnior; Fabricio R Conceição; Felipe M Salvarani
Journal:  Toxins (Basel)       Date:  2021-08-26       Impact factor: 4.546

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.